Tallac Therapeutics

Burlingame, United States

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

$5.0M raised

Aug 2023

Debt Financing

Biotechnology Health Care Therapeutics

Top Investors

Matrix Partners China venBio Partners Lightstone Ventures Horizon Technology Finance MRL Ventures Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tallac Therapeutics

How much funding has Tallac Therapeutics raised?

Tallac Therapeutics has raised $5.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2023.

Who are Tallac Therapeutics's investors?

Tallac Therapeutics's investors include Matrix Partners China, venBio Partners, Lightstone Ventures, Horizon Technology Finance, MRL Ventures Fund.

Where is Tallac Therapeutics headquartered?

Tallac Therapeutics is headquartered in Burlingame, United States.

What does Tallac Therapeutics do?

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

What stage is Tallac Therapeutics at?

Tallac Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 2, 2023.

MLA

"Tallac Therapeutics — Funding & Investors." VCBacked, August 2, 2023, https://www.vcbacked.co/company/tallac-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Tallac Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tallac-therapeutics

Wikipedia (cite web)

{{cite web |title=Tallac Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tallac-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 2, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K